GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,262,000 | +0.9% | 120,873 | +0.9% | 1.26% | +12.1% |
| Q1 2022 | $5,217,000 | +1.3% | 119,761 | +2.5% | 1.12% | +5.7% |
| Q4 2021 | $5,151,000 | +14.5% | 116,801 | -1.0% | 1.06% | +5.9% |
| Q3 2021 | $4,500,000 | -19.3% | 118,011 | -15.8% | 1.00% | -18.9% |
| Q2 2021 | $5,579,000 | +12.8% | 140,099 | +1.1% | 1.24% | +8.4% |
| Q1 2021 | $4,946,000 | +2.8% | 138,579 | +6.0% | 1.14% | -3.1% |
| Q4 2020 | $4,811,000 | +0.3% | 130,747 | +2.7% | 1.18% | -10.6% |
| Q3 2020 | $4,795,000 | -6.8% | 127,371 | +1.0% | 1.31% | -11.6% |
| Q2 2020 | $5,144,000 | +6.5% | 126,108 | -1.1% | 1.49% | -8.3% |
| Q1 2020 | $4,829,000 | +9.1% | 127,454 | +35.3% | 1.62% | +38.1% |
| Q4 2019 | $4,426,000 | -9.8% | 94,189 | -18.1% | 1.17% | -13.5% |
| Q3 2019 | $4,909,000 | +7.9% | 115,017 | +1.2% | 1.36% | +5.7% |
| Q2 2019 | $4,550,000 | -6.6% | 113,702 | -2.5% | 1.28% | -7.0% |
| Q1 2019 | $4,872,000 | +15.5% | 116,593 | +5.6% | 1.38% | +4.5% |
| Q4 2018 | $4,218,000 | -5.0% | 110,376 | -0.2% | 1.32% | +5.5% |
| Q3 2018 | $4,442,000 | +0.9% | 110,587 | +1.2% | 1.25% | -6.1% |
| Q2 2018 | $4,404,000 | -10.2% | 109,230 | -13.0% | 1.33% | -10.3% |
| Q1 2018 | $4,905,000 | +18.0% | 125,538 | +7.1% | 1.49% | +20.7% |
| Q4 2017 | $4,158,000 | -16.9% | 117,225 | -4.8% | 1.23% | -27.0% |
| Q3 2017 | $5,002,000 | -3.9% | 123,194 | +2.1% | 1.69% | -8.4% |
| Q2 2017 | $5,205,000 | +2.4% | 120,696 | +0.1% | 1.84% | +3.0% |
| Q1 2017 | $5,084,000 | +7.9% | 120,592 | -1.4% | 1.79% | +10.1% |
| Q4 2016 | $4,712,000 | -12.2% | 122,352 | -1.7% | 1.62% | -11.8% |
| Q3 2016 | $5,367,000 | -2.4% | 124,456 | -1.9% | 1.84% | +2.9% |
| Q2 2016 | $5,498,000 | +7.3% | 126,843 | +0.4% | 1.79% | +9.1% |
| Q1 2016 | $5,125,000 | +30.1% | 126,397 | +29.5% | 1.64% | +24.0% |
| Q4 2015 | $3,938,000 | +771.2% | 97,610 | +730.4% | 1.32% | +716.7% |
| Q3 2015 | $452,000 | -10.8% | 11,755 | -3.6% | 0.16% | -4.1% |
| Q2 2015 | $507,000 | -10.6% | 12,190 | -0.8% | 0.17% | -10.6% |
| Q1 2015 | $567,000 | -11.1% | 12,290 | +87685.7% | 0.19% | -10.0% |
| Q4 2014 | $638,000 | -13.8% | 14 | -99.9% | 0.21% | -16.3% |
| Q3 2014 | $740,000 | -14.3% | 16,090 | -0.3% | 0.25% | -14.0% |
| Q2 2014 | $863,000 | +3.4% | 16,140 | +3.3% | 0.29% | 0.0% |
| Q1 2014 | $835,000 | +0.1% | 15,629 | 0.0% | 0.29% | -0.7% |
| Q4 2013 | $834,000 | +9.3% | 15,629 | +2.7% | 0.29% | +1.4% |
| Q3 2013 | $763,000 | -84.2% | 15,220 | -84.2% | 0.29% | -84.5% |
| Q2 2013 | $4,823,000 | – | 96,499 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |